Skip to main content Accessibility help
×
Home
Hostname: page-component-79b67bcb76-6tv95 Total loading time: 0.403 Render date: 2021-05-15T11:26:59.296Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": false, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true }

Identification of four patients with colistin-resistant Escherichia coli containing the mobile colistin resistance mcr-1 gene from a single health system in Michigan

Published online by Cambridge University Press:  10 July 2019

Oryan Henig
Affiliation:
Infectious Diseases Division, Rambam Health Care Campus, Haifa, Israel
Laura J. Rojas
Affiliation:
Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio Department of Medicine, Case Western Reserve University, Cleveland, Ohio
Michael A. Bachman
Affiliation:
Department of Pathology, University of Michigan, Medical School, Ann Arbor, Michigan
Susan D. Rudin
Affiliation:
Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio Department of Medicine, Case Western Reserve University, Cleveland, Ohio
Brenda M. Brennan
Affiliation:
Michigan Department of Health and Human Services (MDHHS)Bureau of Epidemiology and Population Health, Lansing, Michigan
Marty K. Soehnlen
Affiliation:
Michigan Department of Health and Human Service (MDHHS)Bureau of Laboratories, Lansing, Michigan
Kelly L. Jones
Affiliation:
Michigan Department of Health and Human Service (MDHHS)Bureau of Laboratories, Lansing, Michigan
John P. Mills
Affiliation:
Department of Medicine, Division of Infectious Diseases, University of Michigan, Medical School, Ann Arbor, Michigan
Carey R. Dombecki
Affiliation:
Department of Infection Prevention and Epidemiology, Michigan Medicine, Ann Arbor, Michigan
Amanda M. Valyko
Affiliation:
Department of Infection Prevention and Epidemiology, Michigan Medicine, Ann Arbor, Michigan
Steven H. Marshall
Affiliation:
Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio Department of Medicine, Case Western Reserve University, Cleveland, Ohio Department of Microbiology and Molecular Biology, Case Western Reserve University, Cleveland, Ohio
Robert A. Bonomo
Affiliation:
Department of Medicine, Case Western Reserve University, Cleveland, Ohio Department of Microbiology and Molecular Biology, Case Western Reserve University, Cleveland, Ohio Departments of Pharmacology, Molecular Biology and Microbiology, Biochemistry, and Proteonomic and Bioinformatics, Case Western Reserve University School of Medicine, Cleveland, Ohio
Keith S. Kaye
Affiliation:
Department of Medicine, Division of Infectious Diseases, University of Michigan, Medical School, Ann Arbor, Michigan
Laraine Washer
Affiliation:
Infectious Diseases Division, Rambam Health Care Campus, Haifa, Israel Department of Infection Prevention and Epidemiology, Michigan Medicine, Ann Arbor, Michigan
Corresponding
E-mail address:

Abstract

Clinical Enterobacteriacae isolates with a colistin minimum inhibitory concentration (MIC) ≥4 mg/L from a United States hospital were screened for the mcr-1 gene using real-time polymerase chain reaction (RT-PCR) and confirmed by whole-genome sequencing. Four colistin-resistant Escherichia coli isolates contained mcr-1. Two isolates belonged to the same sequence type (ST-632). All subjects had prior international travel and antimicrobial exposure.

Type
Concise Communication
Copyright
© 2019 by The Society for Healthcare Epidemiology of America. All rights reserved. 

Access options

Get access to the full version of this content by using one of the access options below.

References

Kaye, KS, Pogue, JM, Tran, TB, Nation, RL, Li, J. Agents of last resort: polymyxin resistance. Infect Dis Clin N Am 2016;30:391414.CrossRefGoogle ScholarPubMed
Monaco, M, Giani, T, Raffone, M, et al. Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014. Euro Surveill 2014;19(42). pii: 20939.CrossRefGoogle Scholar
Gao, R, Hu, Y, Li, Z, et al. Dissemination and mechanism for the mcr-1 colistin resistance. PLoS Pathog 2016;12(11):e1005957.CrossRefGoogle ScholarPubMed
Liu, YY, Wang, Y, Walsh, TR, et al. Emergence of plasmid-mediated colistin resistance mechanism mcr-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 2016;16:161168.CrossRefGoogle ScholarPubMed
Alert to US healthcare facilities: first mcr-1 gene in E. coli bacteria found in a human in the United States. Centers for Disease Control and Prevention website. https://emergencycdcgov/han/han00390asp. Accessed April 12, 2019.Google Scholar
Tracking the mcr gene. Centers for Disease Control and Prevention website. https://wwwcdcgov/drugresistance/biggest-threats/tracking/mcrhtml. Accessed April 12, 2019.Google Scholar
Skov, RL, Monnet, DL. Plasmid-mediated colistin resistance (mcr-1 gene): three months later, the story unfolds. Euro Surveill 2016;21:30155.10.2807/1560-7917.ES.2016.21.9.30155CrossRefGoogle ScholarPubMed
Marchaim, D, Chopra, T, Bhargava, A, et al. Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: the role of antimicrobial stewardship. Infect Control Hosp Epidemiol 2012;33:817830.10.1086/666642CrossRefGoogle ScholarPubMed
McGann, P, Snesrud, E, Maybank, R, et al. Escherichia coli harboring mcr-1 and blaCTX-M on a novel IncF plasmid: first report of mcr-1 in the United States. Antimicrob Agents Chemother 2016;60:44204421.CrossRefGoogle ScholarPubMed
Arcilla, MS, van Hattem, JM, Matamoros, S, et al. Dissemination of the mcr-1 colistin resistance gene. Lancet Infect Dis 2016;16:147149.CrossRefGoogle ScholarPubMed
Supplementary material: File

Henig et al. supplementary material

Henig et al. supplementary material 1

Download Henig et al. supplementary material(File)
File 22 KB

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Identification of four patients with colistin-resistant Escherichia coli containing the mobile colistin resistance mcr-1 gene from a single health system in Michigan
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Identification of four patients with colistin-resistant Escherichia coli containing the mobile colistin resistance mcr-1 gene from a single health system in Michigan
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Identification of four patients with colistin-resistant Escherichia coli containing the mobile colistin resistance mcr-1 gene from a single health system in Michigan
Available formats
×
×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *